In June 2006, a Chinese high court reinstated patent protection for Pfizer's erectile dysfunction drug, Viagra. Soon after, the Chinese government committed $500 million to food and drug regulation – more than was spent in the previous seven years combined. Then, in July 2007, Zheng Xiaoyu – China's former head of the State Food and Drug Administration – was executed for taking bribes. These three events signaled China's drug market was finally open for business. And it's the fastest-growing drug market in the world. But here's the catch: It's easy to find drug companies working in China... but not so easy to find ones that will let you profit off the trend. Let me explain... Fueled by a massive aging population, rapid economic development, and urbanization, the pace of China's medical spending over the past five years has been double its
[More...]
